Crinetics Pharmaceuticals Inc (CRNX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2018 | 03-2018 | 12-2017 | 09-2017 | 06-2017 | |
| Sales | 657 | 442 | 535 | 640 | 832 |
| Gross Profit | 657 | 442 | 530 | 640 | 832 |
| Operating Expenses | 6,340 | 5,968 | 3,049 | 3,014 | 2,475 |
| Operating Income | -5,683 | -5,526 | -2,514 | -2,374 | -1,643 |
| Interest Expense | 0 | 0 | -7 | 2 | 3 |
| Other Income | 115 | 62 | -30 | -6 | -2 |
| Pre-tax Income | -5,568 | -5,464 | -2,537 | -2,382 | -1,648 |
| Net Income Continuous | -5,568 | -5,464 | -2,537 | -2,382 | -1,648 |
| Net Income | $-5,568 | $-5,464 | $-2,537 | $-2,382 | $-1,648 |
| EPS Basic Total Ops | -2.41 | -2.92 | -1.61 | -1.67 | -1.22 |
| EPS Basic Continuous Ops | -2.41 | -2.92 | -1.62 | -1.67 | -1.22 |
| EPS Diluted Total Ops | -2.41 | -2.92 | -1.61 | -1.67 | -1.22 |
| EPS Diluted Continuous Ops | -2.41 | -2.92 | -1.62 | -1.67 | -1.22 |
| EBITDA(a) | $-5,607 | $-5,478 | $-2,474 | $-2,346 | $-1,618 |